Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial
Authors
Keywords
-
Journal
Targeted Oncology
Volume 11, Issue 6, Pages 815-824
Publisher
Springer Nature
Online
2016-12-07
DOI
10.1007/s11523-016-0462-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
- (2015) P. Jiménez-Fonseca et al. CANCER AND METASTASIS REVIEWS
- Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification
- (2015) Stefan M Brunner et al. BMC Surgery
- Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors
- (2014) Juan W. Valle et al. CANCER TREATMENT REVIEWS
- Learning experiences with sunitinib continuous daily dosing in patients with pancreatic neuroendocrine tumours
- (2014) E. Raymond et al. Current Oncology
- Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib
- (2013) Aaron I. Vinik et al. Therapeutic Advances in Gastroenterology
- Patient Preferences Versus Physicians’ Judgement: Does it Make a Difference in Healthcare Decision Making?
- (2013) Axel C. Mühlbacher et al. Applied Health Economics and Health Policy
- Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
- (2012) D Cella et al. BRITISH JOURNAL OF CANCER
- TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
- (2012) G. Rindi et al. JNCI-Journal of the National Cancer Institute
- Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung)
- (2011) Su-Jung Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
- (2011) Matthew H Kulke et al. Journal of Hematology & Oncology
- Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate
- (2011) S. Khan et al. JOURNAL OF NUCLEAR MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma
- (2011) Ateesha F. Mohamed et al. PHARMACOECONOMICS
- Development of the Norfolk Quality of Life Tool for Assessing Patients With Neuroendocrine Tumors
- (2009) Etta Vinik et al. PANCREAS
- Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon Alfa
- (2009) David Cella et al. Journal of Oncology Practice
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer
- (2007) M.S. Carey et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started